home about us journals search

African Journal of Pharmacy and Pharmacology

     
   AJPP Home
   About AJPP
   Submit Manuscripts
   Instructions for Authors
   Editors
   Call For Paper
   Archive
   Email Alerts
 

 Afr. J. Pharm. Pharmacol.

 Vol. 2 No.4

  Viewing options:

    • Abstract
    •Reprint(PDF) (152K)

  Search Pubmed for articles by:

 
Takougang I
 
Amazigo UV

  Other links:
  PubMed Citation
  Related articles in PubMed

Related Journals

Journal of Cell & Animal Biology
African Journal  of Environmental Science & Technology
Biotechnology & Molecular Biology Reviews

African Journal of Biochemistry Research

African Journal of Microbiology Research
African Journal of Pure & Applied Chemistry
African Journal of Food Science
African Journal of Biotechnology
African Journal of Pharmacy & Pharmacology

African Journal of Plant Science
Journal of Medicinal Plant Research
International Journal of Physical Sciences
Scientific Research and Essays
 

African Journal of Pharmacy and Pharmacology Vol. 2(4), pp. 077-082 June,  2008

© 2008 Academic Journals  

 

 

Full Length Research Paper

 

Does alcohol consumption increase the risk of severe adverse events to ivermectin treatment?

 

Takougang I.1*, Ngogang J.2, Sihom F.1, Ntep M.3, Kamgno J.3, Eyamba A.4, ZouréH.5, Noma M.5 and Amazigo U. V.5

 

1Department of Public Health, Faculty of Medicine and Biomedical Sciences; University of Yaoundé 1, P. O. Box 1364 Yaoundé, Cameroon.

2Department of Physiological Sciences, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, P. O. Box 1364 Yaoundé, Cameroon.

3National Programme for Onchocerciasis Control, Ministry of Public Health, Yaoundé, Cameroon.

4Carter Center/Global 2000, Yaoundé, Cameroon.

5African Programme for Onchocerciasis Control, BP 155 Ouagadougou, Burkina Faso.

 

 *Corresponding author: E-mail: itakougang@yahoo.com

 

Accepted June 2, 2008

 

   Abstract

 

The present investigation is a case-control study designed to assess the level of association between alcohol consumption and the occurrence of severe adverse reaction (SAE) following ivermectin consumption. Thirty-six (36)  cases of SAE occurred in the health districts of Bankim, Nanga Eboko, Obala, Okola and Sa’a. Case and control (43) individuals were submitted to a questionnaire related to their alcohol consumption 24 before and 24 to 48 h following ivermectin intake. An in-depth interview of siblings and local health worker was conducted to assess alcohol consumption around Mectizan intake. The degree of alcohol use was assessed using the level of serum transaminases and the alcohol use disorder identification test (AUDIT). The alcoholic beverages of the study communities were conventional such as beer, whisky, or locally made. Locally produced beverages included “arki” (“Odontol”, “Hah”, ...) and palm wine. The bark, sap or fruit of plants adjuvant are known to contain alkaloids and tannins which are potent neurotropic substances. The likelihood of developing SAE among cases and controls did not differ significantly with history of consumption of alcoholic beverages. Nor did it differ for other indicators of chronic alcohol consumption.

 

Key words: Alcohol consumption, onchocerciasis, AUDIT, serious adverse events, encephalopathy.

Advertise on AJPP | Terms of Use | Privacy Policy | Help

© Academic Journals 2002 - 2008